Home › Atopic Dermatitis (Eczema) › Georgia
Atopic Dermatitis (Eczema) clinical trials in Georgia
9 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in Georgia.
Cities in Georgia
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Marietta Dermatology Clinical Research, Inc., Marietta
- Aeroallergy Research Laboratories of Savannah, Inc, Savannah
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Macon
RecruitingPhase 3
6 Months – 11 Years · All sexes · Updated Nov 9, 2026 · NCT06311682First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Rophe Adult and Pediatric Medicine, Union City
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Skin Care Physicians of Georgia, Macon
- Marietta Dermatology Clinical Research, Inc., Marietta
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Douglasville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07003425This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Skin Care Physicians of Georgia - Macon- Site Number : 8400034, Macon
RecruitingObservational study
Ages 12 and older · All sexes · Updated Nov 2, 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Atlanta
- Novartis Investigative Site, Macon
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Atlanta
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Georgia Skin & Cancer Center, Savannah
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.